Download Leukaemia Section t(2;3)(p23;q21) Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Epigenetics of neurodegenerative diseases wikipedia , lookup

Genome (book) wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Neuronal ceroid lipofuscinosis wikipedia , lookup

Protein moonlighting wikipedia , lookup

Designer baby wikipedia , lookup

Gene therapy of the human retina wikipedia , lookup

Medical genetics wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

Genetic code wikipedia , lookup

Expanded genetic code wikipedia , lookup

Point mutation wikipedia , lookup

NEDD9 wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Leukaemia Section
Short Communication
t(2;3)(p23;q21)
Jean-Loup Huret
Genetics, Dept Medical Information, UMR 8125 CNRS, University of Poitiers, CHU Poitiers Hospital, F86021 Poitiers, France (JLH)
Published in Atlas Database: August 2001
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t0203ID1217.html
DOI: 10.4267/2042/37789
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2001 Atlas of Genetics and Cytogenetics in Oncology and Haematology
only ALK cases) show clinical features similar to those
of classical ALK+ ALCL: young age, male
predominance, presentation with advanced disease,
systemic symptoms, frequent involvement of
extranodal sites, and a good prognosis. Nothing in
particular is known concerning t(2;3) cases.
Identity
Genes involved and proteins
ALK
Location
2p23
Protein
1620 amino acids; 177 kDa; glycoprotein (200 kDa
mature protein); membrane associated tyrosine kinase
receptor.
t(2;3)(p23;q21) G- banding - Courtesy Melanie Zenger and
Claudia Haferlach.
Clinics and pathology
Disease
TFG (tropomyosin receptor kinasefused gene)
Anaplasic large cell lymphoma: translocations
involving 2p23 are found in more than half cases of
anaplasic large cell lymphoma (ALCL), a high grade
non Hodgkin lymphoma (NHL). They involve ALK,
and are therefore called ALK+ ALCL.
The most frequent ALK+ ALCL being the the
t(2;5)(p23;q35) with NPM1 -ALK fusion protein,
which localises both in the cytoplasm and in the
nucleus.
The t(2;3)(p23;q21) is very rare., and, like other
t(2;Var) involving various partners and ALK, the
fusion protein has a cytoplasmic localization; they are
therefore called "cytoplasm only" ALK+ ALCL.
Location
3q21
Protein
406 amino acids, 44 kDa; widely expressed.
Somatic mutations
Apart from the TFG-ALK herein described (see
below), TFG is also known to de fused to NTRK1 in a
subset of thyroid papillary carcinomas.
Epidemiology
Result of the chromosomal
anomaly
Only 2 cases to date: a 10 yr old girl and a 19 yr old
man.
Hybrid gene
Clinics
Description
5' TFG - 3' ALK.
ALK+ ALCL without the t(2;5) (so called cytoplasmic
Atlas Genet Cytogenet Oncol Haematol. 2001; 5(4)
287
t(2;3)(p23;q21)
Huret JL
Rosenwald A, Ott G, Pulford K, Katzenberger T, Kühl J, Kalla
J, Ott MM, Mason DY, Müller-Hermelink HK. t(1;2)(q21;p23)
and t(2;3)(p23;q21): two novel variant translocations of the
t(2;5)(p23;q35) in anaplastic large cell lymphoma. Blood. 1999
Jul 1;94(1):362-4
Fusion protein
Description
83 kDa and 96-97 kDa; as the breakpoint in TPM3 was
variable, 701 amino acids in the sort er fusion protein,
composed of 138 N-term amino acids from TFG,
including the cioled-coil oligomerization domain fused
to the 562 C-term amino acids from ALK (i.e. the
entire cytoplasmic portion of ALK with the tyrosine
kinase domain); homodimerization of the fusion
protein.
Expression / Localisation
Cytoplasmic localisation (in contrast with the
t(2;5)(p23;q35) with NPM1-ALK, which localizes both
in the cytoplasm and in the nucleus).
Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks
WG. Pathobiology of NPM-ALK and variant fusion genes in
anaplastic large cell lymphoma and other lymphomas.
Leukemia. 2000 Sep;14(9):1533-59
Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K,
Pileri S, Falini B. CD30(+) anaplastic large cell lymphoma: a
review of its histopathologic, genetic, and clinical features.
Blood. 2000 Dec 1;96(12):3681-95
Delsol G, Ralfkiaer E, Stein H, Wright D, Jaffe E. Anaplastic
large cell lymphomas, Primary systemic (T/Null cell type).
WHO Classification of Tumors. Pathology and Genetics of
tumours of Haematopoietic and Lymphoid Tissues . 2001 pp
230-235.
References
Morris SW, Xue L, Ma Z, Kinney MC. Alk+ CD30+ lymphomas:
a distinct molecular genetic subtype of non-Hodgkin's
lymphoma. Br J Haematol. 2001 May;113(2):275-95
Hernández L, Pinyol M, Hernández S, Beà S, Pulford K,
Rosenwald A, Lamant L, Falini B, Ott G, Mason DY, Delsol G,
Campo E. TRK-fused gene (TFG) is a new partner of ALK in
anaplastic large cell lymphoma producing two structurally
different TFG-ALK translocations. Blood. 1999 Nov
1;94(9):3265-8
Atlas Genet Cytogenet Oncol Haematol. 2001; 5(4)
This article should be referenced as such:
Huret JL. t(2;3)(p23;q21). Atlas Genet Cytogenet Oncol
Haematol. 2001; 5(4):287-288.
288
Related documents
Leukaemia Section t(2;22)(p23;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;22)(p23;q11.2) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;5)(p23;q35) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;5)(p23;q35) Atlas of Genetics and Cytogenetics in Oncology and Haematology
232 Lecture supplement 3
232 Lecture supplement 3
Gene Section CARS (cysteinyj-tRNA synthetase) Atlas of Genetics and Cytogenetics
Gene Section CARS (cysteinyj-tRNA synthetase) Atlas of Genetics and Cytogenetics
Gene Section ATIC (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase)
Gene Section ATIC (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase)
Leukaemia Section t(2;5)(p23;q35) SQSTM1/A LK Atlas of Genetics and Cytogenetics
Leukaemia Section t(2;5)(p23;q35) SQSTM1/A LK Atlas of Genetics and Cytogenetics
Anaplastic Large Cell Lymphoma:- a clinico
Anaplastic Large Cell Lymphoma:- a clinico
Gene Section ALK (anaplastic lymphoma kinase) Atlas of Genetics and Cytogenetics
Gene Section ALK (anaplastic lymphoma kinase) Atlas of Genetics and Cytogenetics
Solid Tumour Section Soft Tissue Tumors: Inflammatory myofibroblastic tumor
Solid Tumour Section Soft Tissue Tumors: Inflammatory myofibroblastic tumor
Xcovery to Present at the ASCO Annual Meeting 2016
Xcovery to Present at the ASCO Annual Meeting 2016
Discovering conserved DNA
Discovering conserved DNA
Gene Section IL22RA1 (interleukin 22 receptor, alpha 1)
Gene Section IL22RA1 (interleukin 22 receptor, alpha 1)
New Developments in Cancer Treatment
New Developments in Cancer Treatment
Leukaemia Section Anaplastic large cell lymphoma (ALCL) Atlas of Genetics and Cytogenetics
Leukaemia Section Anaplastic large cell lymphoma (ALCL) Atlas of Genetics and Cytogenetics
Leukaemia Section t(2;9)(p23;q33) TRAF1/ALK Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;9)(p23;q33) TRAF1/ALK Atlas of Genetics and Cytogenetics in Oncology and Haematology
Solid Tumour Section Soft tissue tumors: Inflammatory myofibroblastic tumor
Solid Tumour Section Soft tissue tumors: Inflammatory myofibroblastic tumor
Leukaemia Section Anaplasic large cell lymphoma (ALCL) Atlas of Genetics and Cytogenetics
Leukaemia Section Anaplasic large cell lymphoma (ALCL) Atlas of Genetics and Cytogenetics
Association for Molecular Pathology Certificate of Attendance
Association for Molecular Pathology Certificate of Attendance
Gene Section ALK (anaplastic lymphoma kinase) Atlas of Genetics and Cytogenetics
Gene Section ALK (anaplastic lymphoma kinase) Atlas of Genetics and Cytogenetics
ABOUT LORLATINIB ALK in NSCLC ROS1 in NSCLC
ABOUT LORLATINIB ALK in NSCLC ROS1 in NSCLC
Gene Section ALK (anaplastic lymphoma kinase) Atlas of Genetics and Cytogenetics
Gene Section ALK (anaplastic lymphoma kinase) Atlas of Genetics and Cytogenetics
Indication Title Protocol ID BO28984 (ALEX) Phase Sponsor
Indication Title Protocol ID BO28984 (ALEX) Phase Sponsor